Near‐Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti‐PD Immunotherapy against Metastatic Tumors-Reference-Cited by-同舟云学术

Near‐Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti‐PD Immunotherapy against Metastatic Tumors

Published:2021-12-17 Issue: Volume: Page:2101496
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv Healthcare Materials

Author:

Tan Ya‐Nan¹²^ORCID,Huang Jian‐Dong²³,Li Yong‐Peng⁴,Li Shan‐Shan¹,Luo Min¹,Luo Jie⁵,Lee Anne Wing‐Mui¹⁵,Fu Li⁶,Hu Fu‐Qiang⁷,Guan Xin‐Yuan¹⁵^ORCID

Affiliation:

1. Department of Clinical Oncology The University of Hong Kong‐Shenzhen Hospital Shenzhen 518053 China

2. Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 China

3. School of Biomedical Sciences The University of Hong Kong Hong Kong 00852 China

4. Department of Urology The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group) Shenzhen 518000 China

5. Department of Clinical Oncology The University of Hong Kong Hong Kong 00852 China

6. Guangdong Provincial Key Laboratory of Regional Immunity and Diseases Department of Pharmacology and International Cancer Center Shenzhen University Health Science Center Shenzhen 518060 China

7. College of Pharmaceutical Science Zhejiang University Hangzhou 310058 China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Shenzhen Fundamental Research Program

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202101496

Reference56 articles.

1. CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients

2. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

3. Long Circulation Red-Blood-Cell-Mimetic Nanoparticles with Peptide-Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer

4. Emerging Biological Principles of Metastasis

5. Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering cells or cellular outer membranes as multifaceted vehicles for reinforcing nanomedicine-based pulmonary disease treatment;Nano Today;2024-10

2. Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy;Nanomedicine;2024-07-16

3. At the crossroad of nanotechnology and cancer cell membrane coating: Expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting;Coordination Chemistry Reviews;2024-05

4. The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts;International Journal of Nanomedicine;2024-04

5. Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy;Current Drug Delivery;2024-03